Company Search:
Advanced Search
Sponsored Links
Virbac Company Snapshot
Virbac operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other companies in this sector in France: Vetoquinol Sa (2016 sales of 350.40 million Euro [US$378.81 million] ), Guerbet SA (775.80 million Euro [US$838.70 million] ), and Boiron SA (614.49 million Euro [US$664.31 million] ).

Sales Analysis. Virbac reported sales of 871.83 million Euro (US$942.52 million) for the year ending December of 2016. This represents an increase of 2.3% versus 2015, when the company's sales were 852.62 million Euro. Sales at Virbac have increased during each of the previous five years (and since 2011, sales have increased a total of 40%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Virbac
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 145.50
(Figures in Euro)
1 Week -13.7%   13 Weeks -15.0%  
4 Weeks 4.0%   52 Weeks -14.3%  
Virbac Key Data:
  Ticker: VIRP Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 871,828,000
(Year Ending Jan 2017).
Employees: 4,781
  Currency: Euro Market Cap: 1,226,424,156
  Fiscal Yr Ends: December Shares Outstanding: 8,429,032
  Share Type: Actions Ordinaires Closely Held Shares: 4,278,739
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.